Twin Focus Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,547
Closed -$343K 167
2023
Q2
$343K Hold
1,547
0.07% 147
2023
Q1
$374K Hold
1,547
0.07% 133
2022
Q4
$406K Sell
1,547
-3
-0.2% -$804 0.08% 118
2022
Q3
$349K Hold
1,550
0.08% 126
2022
Q2
$377K Hold
1,550
0.08% 122
2022
Q1
$375K Buy
1,550
+35
+2% +$8.04K 0.07% 135
2021
Q4
$341K Buy
+1,515
New +$320K 0.07% 149
2021
Q1
Sell
-1,179
Closed -$271K 162
2020
Q4
$271K Sell
1,179
-185
-14% -$42.7K 0.08% 127
2020
Q3
$347K Buy
1,364
+85
+7% +$21.1K 0.13% 91
2020
Q2
$302K Buy
1,279
+7
+0.6% +$1.6K 0.12% 100
2020
Q1
$258K Buy
1,272
+28
+2% +$6.12K 0.12% 110
2019
Q4
$300K Hold
1,244
0.1% 143
2019
Q3
$241K Hold
1,244
0.09% 135
2019
Q2
$229K Buy
+1,244
New +$223K 0.1% 123

Other funds holding AMGN

Twin Focus Capital Partners's AMGN Position: Q3 2023 in Review

Twin Focus Capital Partners sold out of Amgen (AMGN) in Q3 2023, closing a stake of 1,547 shares — an estimated $343K sold.

Twin Focus Capital Partners first reported a position in AMGN in Q2 2019 and held it in 14 quarters. The position peaked at $406K in Q4 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Twin Focus Capital Partners reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
  • Twin Focus Capital Partners sold 1,547 Amgen shares in Q3 2023, an estimated $343K.
  • Twin Focus Capital Partners first reported a position in Amgen in Q2 2019 and held it in 14 quarters.
  • Twin Focus Capital Partners's Amgen position peaked at $406K in Q4 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Twin Focus Capital Partners's 13F filing for Q3 2023, filed 13 Nov 2023.